Scaling a Personalized Portfolio: restor3d Completes Key Initiative Following Conformis Acquisition
Acquiring Company
Restor3D
Acquired Company
Conformis
Description
Following the acquisition of Conformis, Inc., restor3d, Inc. has achieved a key initiative by successfully commercializing a previously-cleared additive manufacturing method for patient-specific femoral implants. This achievement holds the potential to deliver clinically differentiated and cost-effective solutions across the orthopaedic landscape, representing a significant step in the era of personalization for total knee replacement.
Quick answer
Restor3D is acquiring Conformis, announced January 16, 2024. Restor3D is based in Durham, North Carolina, United States.
- How much did Restor3D pay for Conformis?
- The deal value was not disclosed.
- What does Restor3D do?
- restor3d is a world leader in patient specific, 3D printed, musculoskeletal implants and driven by the belief that every patient deserves personalized care.
- Where are Restor3D and Conformis based?
- Restor3D is based in Durham, North Carolina, United States. Conformis is based in Billerica, Massachusetts, United States.
- Who are the decision-makers at Restor3D?
- Fundz holds 1 contact at Restor3D. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Healthcare and Medical Equipment Manufacturing
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- XOMA Enters into Agreement to Acquire Kinnate Biopharma for Between $2.3352 and $2.5879 in Cash Per Share Plus a Contingent Value Right (February 16, 2024)
- Novo Holdings to Acquire Catalent (February 5, 2024)
- Synchron Acquires Equity Stake in ACQUANDAS (February 1, 2024)
- CardioFocus Acquires Electrophysiology Division of Galvanize Therapeutics (January 11, 2024)
- Headlands Research completes acquisition of Pharmasite Research, expanding expertise in mental health and CNS research (March 1, 2024)
- Branded Legacy, Inc. signs letter of intent to purchase Sycamore BioPharma, LLC, to strengthen its position in the BioTech industry (March 1, 2024)
Who to call at Restor3D, and when
When Restor3D changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Restor3D raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Restor3D, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Restor3D. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Restor3D makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Conformis?
Conformis was acquired by Restor3D, based in Durham. The deal was reported on January 16, 2024. restor3d is a world leader in patient specific, 3D printed, musculoskeletal implants and driven by the belief that every patient deserves personalized care. Restor3D is privately held and operates in Other.
When did Restor3D acquire Conformis?
Restor3D's acquisition of Conformis was reported on January 16, 2024. Following the acquisition of Conformis, Inc., restor3d, Inc. has achieved a key initiative by successfully commercializing a previously-cleared additive manufacturing method for patient-specific femoral implants. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Conformis do?
Conformis, Inc. is a publicly traded medical device company based in Massachusetts. It was founded in 2004 to provide dramatic advancements in patient care by utilizing imaging technology to create personalized, patient-specific implants and instrumentation. It is privately held, operating in Medical Equipment Manufacturing, and is based in Billerica.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.